A latest mother from Cornwall, England, has regained much of her sight after a novel treatment involving plasma donation, offering hope to others facing similar autoimmune-related vision loss. Jessica Kent-Hazledine, 33, experienced a sudden and frightening loss of vision in both eyes shortly after giving birth to her son, fearing she would never see her child grow up. The treatment, provided through a new service run by NHS Blood and Transplant (NHSBT), utilized plasma exchange to halt an autoimmune response attacking her optic nerves.
The experience began just two weeks after the birth of her son, when Ms. Kent-Hazledine first noticed blurred vision in her left eye. Initially attributing it to sleep deprivation – a common experience for new parents – she soon found her vision deteriorating rapidly. Within days, the vision in her right eye began to fail as well, prompting an urgent visit to medical professionals. “I was terrified,” she recalled. “I thought I wouldn’t be able to see my baby grow up, wouldn’t be able to see his face change or when he took his first steps.”
The diagnosis pointed to an autoimmune condition where antibodies in her blood were attacking the protective layer around the nerve fibres in her eyes. Standard treatments offered limited relief, leading doctors to explore a more innovative approach: therapeutic plasma exchange. This procedure, now available through the NHSBT’s new therapeutic apheresis service (TAS) in the South West, involves removing a patient’s plasma and replacing it with donor plasma, effectively neutralizing the harmful antibodies. The NHSBT states that apheresis is a specialist treatment used for a range of complex conditions, and the new service aims to develop it more accessible to patients across the region. More information about the NHSBT’s therapeutic apheresis service can be found on their website.
Understanding Plasma Exchange and Autoimmune Conditions
Plasma exchange, also known as plasmapheresis, is a medical procedure used to treat a variety of autoimmune diseases and other conditions where the blood contains harmful antibodies or other substances. According to the Mayo Clinic, the process involves removing plasma from the blood and separating it from the blood cells. The blood cells are then returned to the body along with a replacement fluid, which can be either donor plasma or a plasma substitute. In Ms. Kent-Hazledine’s case, the donor plasma helped to dilute and remove the antibodies attacking her optic nerves.
Autoimmune diseases occur when the body’s immune system mistakenly attacks its own tissues and organs. These conditions can affect various parts of the body, and the symptoms can vary widely depending on the specific disease. Vision loss due to autoimmune conditions is relatively rare, but can be devastating. Early diagnosis and treatment are crucial to prevent permanent damage.
A Pioneering Treatment in Cornwall
Ms. Kent-Hazledine was the first patient in Cornwall to benefit from the new TAS service, which currently operates in collaboration with four hospitals in the region. She underwent five cycles of plasma exchange, reporting noticeable improvements after the third session. “By the fifth [exchange], I felt pretty much back to myself; it felt like magic,” she said. Today, she has clear vision in her right eye and approximately 75% vision in her left eye, allowing her to fully participate in her son’s life.
The expansion of therapeutic apheresis services within the NHS represents a significant step forward in providing access to specialized treatments for complex conditions. Previously, patients requiring this type of therapy often had to travel long distances to access specialized centers. The NHSBT aims to continue expanding the service to other regions, making it more readily available to those who need it.
The Importance of Plasma Donation
Ms. Kent-Hazledine’s story underscores the critical role of blood and plasma donation in supporting innovative medical treatments. “I don’t think people realise just how much good donation can do,” she stated. “We all know blood can be used in emergencies, but it can also be used to help so many people like me.” The NHSBT is continually seeking new donors to ensure a stable supply of both blood and plasma. Individuals interested in learning more about donating blood or plasma can visit the NHS Blood and Transplant website.
Plasma donation is a process where the liquid portion of your blood (plasma) is collected, and the red blood cells are returned to your body. Plasma is rich in antibodies and proteins used to treat a variety of conditions, including autoimmune diseases, bleeding disorders, and burn victims. The demand for plasma is increasing, and regular donations are vital to meet the needs of patients.
Looking ahead, the NHSBT will continue to monitor the outcomes of patients receiving therapeutic apheresis and refine the service based on clinical data. The organization is also actively researching new applications for plasma exchange and other apheresis techniques. The next scheduled review of the TAS service’s performance is set for early next year, where data on patient outcomes and service utilization will be presented.
This remarkable recovery highlights the power of medical innovation and the generosity of blood and plasma donors. Share this story to raise awareness about the life-changing potential of plasma donation and the importance of supporting research into autoimmune diseases. We welcome your thoughts and experiences in the comments below.
